There wasn't too much excitement in Exelixis today which only managed to move up 0.70% on the day.
The Biotechnology company isn't at an immediate support or resistance level that might be predictive. Exelixis has been drifting up over the last few months, we'll see if it has the energy to keep moving in the right direction. EXEL might find some support at the 19 level, buyers might push the price back up from here. But it's not very clear what will happen.
The analysts feel fairly neutral on the prospects for Exelixis but a little more positive than negative. The current Analysts Sentiment Score is 10.04. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. Royal Bank of Canada gave a boost to their price target and moved to $28.00 from $26.00 on 2024-02-07. On 2024-02-02 Stifel Nicolaus increased their price target by 8.7% to $25.00. On 2024-01-30 Barclays increased their price target by 4.17% to $25.00. William Blair reiterated a rating of Outperform on 2024-01-26. On 2023-12-19 BTIG Research started covering Exelixis with a rating of Buy and added a price target of $27.00. Citigroup initiated a rating of Buy on 2023-12-15 and provided a price target of $31.00. JMP Securities reiterated a rating of Market Outperform on 2023-12-14 and added a price target of $27.00. Morgan Stanley gave a boost to their price target and moved to $23.00 from $22.00 on 2023-11-02. Bank of America gave a boost to their price target and moved to $27.00 from $25.00 on 2023-10-12. Guggenheim reiterated a rating of Buy on 2023-10-11 and they set their price target at $30.00.
Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
---|---|---|---|---|---|
EXEL | 10.04 | 13.29 | 0 | 7.24 | -0.45 |
Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
---|---|---|
EXEL | 0.00 | 0.00 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
---|---|---|---|---|---|
EXEL | 3.36 | %2.8 | 3.7 | 5.544 | 8560000 |
Segment | Count | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest | Analysts Ratings ? |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biotechnology | 95 | 0.79 | -3.72 | -2.26 | -0.85 | 7.67 | 40.04 | 55.08 | 6.66 | 6.30 | 3.43 | -14013.76 | -12974.30 | 16.84 | 4.74 | 9.36 | 8.41 |
Healthcare | 230 | 0.88 | -1.52 | -0.30 | -2.16 | 5.72 | 27.64 | 53.66 | 8.86 | 8.57 | 8.32 | -12704.99 | -11984.82 | 18.91 | 4.24 | 6.74 | 5.55 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
Ticker | Social Sentiment(1-10) |
---|---|
EXEL |
Company | Score | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest Score |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SAGE | Sage Therapeutics, Inc | 0.72 | 0.00 | -8.57 | -37.45 | -37.85 | -56.63 | -74.61 | 31 | -168.21 | -178.82 | -69.30 | -149709.64 | -1968.67 | 0 | 0 | 12.6533 |
AGIO | Agios Pharmaceuticals, In | 0.64 | 0.39 | -1.41 | 21.16 | 20.41 | 67.08 | 149.75 | 88 | 26.04 | 40.64 | 75.74 | 0.00 | -38650.68 | 0 | 0 | 10.8809 |
DNLI | Denali Therapeutics Inc. | 0.62 | 0.33 | -14.17 | -7.64 | -0.37 | 26.79 | 34.10 | 69 | 74.38 | 103.30 | 59.38 | 116.84 | -22833.86 | 0 | 0 | 11.2371 |
KURA | Kura Oncology, Inc. | 0.58 | -0.31 | -3.52 | -10.52 | -21.00 | -25.76 | 70.34 | 59 | -12.34 | -8.94 | -6.18 | -4497.47 | -12834.13 | 0 | 0 | 7.89025 |
TGTX | TG Therapeutics, Inc. | 0.57 | 2.74 | 0.99 | 34.15 | 33.40 | 83.45 | 152.84 | 89 | 30.70 | 47.90 | 31.40 | 170.42 | -21464.95 | 0 | 0 | 20.848 |
HALO | Halozyme Therapeutics, In | 0.55 | 2.12 | -15.20 | -7.18 | -28.97 | 4.19 | 17.70 | 66 | 10.64 | 30.41 | 45.47 | 190.83 | -31629.67 | 100 | 0 | 5.27519 |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.